Mark the opening date on the vial with a permanent marker
In clinical GLP-1 guidelines, the 2.4 mg strength is universally recognized as the final destination. It is the **therapeutic maintenance plateau**. It is explicitly not a starter dose. After your body adapts during the 0.25mg, 0.5mg, 1mg, and 1.7mg introductory periods, switching to the 2.4 mg pen provides the consistent, deep receptor saturation required to maintain your weight loss achievements indefinitely and permanently recondition your long-term metabolic health
We use a lot of medications off-label
This phenomenon, known as the incretin effect, is greatly reduced in diabetics, a difference that led to the development of analogues of incretin GLP-1 and GIP
Current problems with the pancreas or kidneys
If a pharmacy or compounding facility hands you a different syringe type, ask the prescriber to convert the dose to that syringes markings in writing before the first injection